Regulatory cells and human cancer

This publication has 78 references indexed in Scilit:

• CD4⁺CD25⁺FOXP3⁺ regulatory T cells from human thymus and cord blood suppress antigen‐specific T cell responses
  Immunology, 2005
• Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T?cells
  European Journal of Immunology, 2005
• Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
  The Journal of Experimental Medicine, 2005
• Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma
  Human Immunology, 2004
• Human CD4+CD25+ regulatory T cells
  Seminars in Immunology, 2004
• CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
  European Journal of Immunology, 2004
• Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma
  The Journal of Experimental Medicine, 2002
• Infectious Tolerance
  The Journal of Experimental Medicine, 2002
• Selective expression of interleukin-10 gene within glioblastoma multiforme
  Brain Research, 1994
• T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
  The Journal of Experimental Medicine, 1980